Searched for: in-biosketch:yes
person:frangb01
Amyloidosis
Ghiso, Jorge; Vidal, Ruben; Gallo, Gloria; Fragione, Blas
Amiloidose e um termo generico que descreve amplo espectro de doencas caracterizadas pela deposicao de proteinas fibrilares insoluveis em diversos orgaos. As fibrilas depositadas compoem-se predominantemente de proteinas de baixo peso molecular que sao normalmente soluveis sob condicoes fisiologicas. Todos os tipos de amiloide compartilham propriedades fisicas, estruturais e tintoriais comuns: conformacao em placa beta, alto grau de insolubilidade e aparencia fibrilar a microscopia eletronica...
ORIGINAL:0006463
ISSN: 0482-5004
CID: 90048
APOLIPOPROTEIN-E AMYLOID IN ALZHEIMERS PLAQUE [Meeting Abstract]
WISNIEWSKI, T; GOLABEK, A; LALOWSKI, M; VOGEL, T; FRANGIONE, B
ISI:A1995QX38500017
ISSN: 0022-3069
CID: 97647
Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E
Castano EM; Prelli F; Wisniewski T; Golabek A; Kumar RA; Soto C; Frangione B
A central event in Alzheimer's disease is the conformational change from normally circulating soluble amyloid beta peptides (A beta) and tau proteins into amyloid fibrils, in the form of senile plaques and neurofibrillary tangles respectively. The apolipoprotein E (apoE) gene locus has recently been associated with late-onset Alzheimer's disease. It is not know whether apoE plays a direct role in the pathogenesis of the disease. In the present work we have investigated whether apoE can affect the known spontaneous in vitro formation of amyloid-like fibrils by synthetic A beta analogues using a thioflavine-T assay for fibril formation, electron microscopy and Congo Red staining. Our results show that, under the conditions used, apoE directly promotes amyloid fibril formation, increasing both the rate of fibrillogenesis and the total amount of amyloid formed. ApoE accelerated fibril formation of both wild-type A beta-(1-40) and A beta-(1-40A), an analogue created by the replacement of valine with alanine at residue 18, which alone produces few amyloid-like fibrils. However, apoE produced only a minimal effect on A beta-(1-40Q), found in the Dutch variant of Alzheimer's disease. When recombinant apoE isoforms were used, apoE4 was more efficient than apoE3 at enhancing amyloid formation. These in vitro observations support the hypothesis that apoE acts as a pathological chaperone, promoting the beta-pleated-sheet conformation of soluble A beta into amyloid fibres, and provide a possible explanation for the association of the apoE4 genetic isoform with Alzheimer's disease
PMCID:1136559
PMID: 7534068
ISSN: 0264-6021
CID: 8000
S182 protein in Alzheimer's disease neuritic plaques [Letter]
Wisniewski T; Palha JA; Ghiso J; Frangione B
PMID: 7475795
ISSN: 0140-6736
CID: 7909
Amyloid A beta-1-42 does not lead to senile plaques in the canine aging model of Alzheimer's disease
Lalowski, M.; Strosznajder, J.; Russel, M.; Bobik, M.; Frangione, B.; Wisniewski, T.
BIOSIS:PREV199698573706
ISSN: 0065-1400
CID: 97644
AMYLOID A-BETA-1-42 DOES NOT LEAD TO ALZHEIMERS LESIONS IN AGED DOGS [Meeting Abstract]
LALOWSKI, M; GOLABEK, A; BOBIK, M; RUSSELL, M; FRANGIONE, B; WISNIEWSKI, T
ISI:A1995QX38500101
ISSN: 0022-3069
CID: 97645
Familial cerebral amyloid angiopathy (British type) with nonneuritic amyloid plaque formation may be due to a novel amyloid protein [Letter]
Ghiso J; Plant GT; Revesz T; Wisniewski T; Frangione B
PMID: 7751849
ISSN: 0022-510x
CID: 7904
Two conformational states of amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease
Soto C; Frangione B
Since the discovery of soluble amyloid-beta (sA beta), it became clear that the same amino acid sequence can have both a fibrillar or a soluble state. In this work, we describe the isolation of two different species derived from synthetic A beta(1-40) differing in their conformational and fibrillogenesis properties. The separation was performed taking advantage of the fact that only one species is sedimentable by centrifugation after 2 weeks of incubation at 1 mg/ml. One species is highly amyloidogenic (A beta ac) and has an antiparallel beta-sheet structure and the other one is poorly amyloidogenic (A beta nac) and contains mainly random coil or alpha-helix structure. Chemical changes were not detected in the primary structure of both species and the differences in the physical properties and very likely in biological behaviour are thought to have a conformational basis. We propose that the transformation of the non-amyloidogenic into the amyloidogenic conformation could be the fundamental event in the pathological polymerization of sA beta and in the development of Alzheimer's disease
PMID: 7777177
ISSN: 0304-3940
CID: 6753
APOLIPOPROTEIN-E IN ALZHEIMERS-DISEASE [Meeting Abstract]
WISNIEWSKI, T; GOLABEK, A; LALOWSKI, M; VOGEL, T; FRANGIONE, B
ISI:A1995RN98500186
ISSN: 0364-5134
CID: 97646
Amyloidosis in Alzheimer's disease [Comment]
Wisniewski T; Frangione B
PMID: 7677907
ISSN: 0140-6736
CID: 7908